Institutional members access full text with Ovid®

Share this article on:

Cytomegalovirus Infection in Pregnancy

Parikh, Laura MD; Gomez-Lobo, Veronica MD

Topics in Obstetrics & Gynecology: June 15th, 2013 - Volume 33 - Issue 11 - p 1–5
doi: 10.1097/01.PGO.0000432438.03460.3e
Article

Dr. Parikh is Resident, and Dr. Gomez-Lobo is Associate Professor, Department of Obstetrics & Gynecology, Medstar Washington Hospital Center, 110 Irving St, St 5B-63, Washington, DC 20010; E-mail: laura.i.parikh@medstar.net.

All faculty and staff in a position to control the content of this CME activity and their spouses/life partners (if any) have disclosed that they have no financial relationships with, or financial interests in, any commercial organizations pertaining to this educational activity.

The authors have disclosed that the U.S. Food and Drug Administration has not approved the use of ganciclovir and cytomegalovirus hyperimmunoglobulin for the treatment of cytomegalovirus infection in pregnancy as discussed in this article. Please consult the products' labeling for approved information.

Lippincott Continuing Medical Education Institute, Inc., is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Lippincott Continuing Medical Education Institute, Inc., designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

To earn CME credit, you must read the CME article and complete the quiz and evaluation on the enclosed answer form, answering at least seven of the 10 quiz questions correctly. This activity expires on June 14, 2014.

© 2013 by Lippincott Williams & Wilkins, Inc.
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website